Recombinant Human LARS2 protein (GST tag N-Terminus)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human LARS2 protein (GST tag N-Terminus) is a Human Full Length protein, in the 1 to 903 aa range, expressed in Wheat germ, suitable for ELISA, WB.
View Alternative Names
KIAA0028, LARS2, Leucyl-tRNA synthetase, LeuRS
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Human LARS2 protein (GST tag N-Terminus) (AB161621)
ab161621 on a 12.5% SDS-PAGE stained with Coomassie Blue.
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
LARS2 facilitates the translation of mitochondrial-encoded proteins by charging tRNA with leucine. It operates as a monomer and does not participate in a larger complex. This charging process is essential for maintaining mitochondrial function and energy production ensuring the correct synthesis of respiratory chain components. LARS2 thereby provides support for the translation machinery within mitochondria.
Pathways
LARS2 plays an indispensable role within the mitochondrial translation system. It directly influences the oxidative phosphorylation pathway by enabling the synthesis of components important for electron transport and ATP production. LARS2 interacts functionally with other mitochondrial tRNA synthetases like GARS2 and YARS2 contributing to the efficient translation of proteins fundamental for cellular respiration.
Specifications
Form
Liquid
General info
Function
Catalyzes the attachment of leucine to its cognate tRNA.
Sequence similarities
Belongs to the class-I aminoacyl-tRNA synthetase family.
Subcellular localisation
Mitochondrion matrix
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com